The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 Chemokine receptor antagonist

22Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

[D-Lys3]-Growth Hormone Releasing Peptide-6 (DLS) is widely utilized in vivo and in vitro as a selective ghrelin receptor (GHS-R) antagonist. This antagonist is one of the most common antagonists utilized in vivo to block GHS-R function and activity. Here, we found that DLS also has the ability to modestly block chemokine function and ligand binding to the chemokine receptor CCR5. The DLS effects on RANTES binding and Erk signaling as well as calcium mobilization appears to be much stronger than its effects on MIP-1 a and MIP-113. CCR5 have been shown to act as major co-receptor for HIV-1 entry into the CD4 positive host cells. To this end, we also found that DLS blocks M-tropic HIV-1 propagation in activated human PBMCs. These data demonstrate that DLS may not be a highly selective GHS-R1 a inhibitor and may also effects on other G-protein coupled receptor (GPCR) family members. Moreover, DLS may have some potential clinical applications in blocking HIV infectivity and CCR5-mediated migration and function in various inflammatory disease states. © Ivyspring International Publisher.

References Powered by Scopus

Cancer and the chemokine network

2036Citations
N/AReaders
Get full text

A receptor in pituitary and hypothalamus that functions in growth hormone release

1883Citations
N/AReaders
Get full text

The role of mononuclear phagocytes in HTLV-III/LAV infection

1537Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Ghrelin is a persistent biomarker for chronic stress exposure in adolescent rats and humans

58Citations
N/AReaders
Get full text

Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway

49Citations
N/AReaders
Get full text

Growth hormone secretagogue receptor signalling affects high-fat intake independently of plasma levels of ghrelin and LEAP2, in a 4-day binge eating model

45Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Patel, K., Dixit, V. D., Lee, J. H., Kim, J. W., Schaffer, E. M., Nguyen, D., & Taub, D. D. (2012). The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 Chemokine receptor antagonist. International Journal of Medical Sciences, 9(1), 51–58. https://doi.org/10.7150/ijms.9.51

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

50%

Researcher 4

22%

Lecturer / Post doc 3

17%

Professor / Associate Prof. 2

11%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

46%

Agricultural and Biological Sciences 3

23%

Neuroscience 2

15%

Immunology and Microbiology 2

15%

Save time finding and organizing research with Mendeley

Sign up for free